Urgent Warning about proposed Monkeypox Treatments 23/8/2022

On the 4th of August, 2022, the Australian Government announced the use of two vaccines for the pre and post-treatment of Monkeypox.

The two vaccines announced were the Bavarian-Nordic (3rd Generation) "Jynneos" Vaccine and the ACAM2000 (Smallpox) Vaccine.

 The main difference between the two vaccines, other than the year they were developed, is the Virus used to manufacture them.

The Bavarian-Nordic "Jynneos" vaccination uses an inactive virus sample, whereas, the ACAM2000 Smallpox vaccine uses a highly dangerous and contagious active virus known as the Vaccinia Virus.

It was well documented by the CDC in 1988 as a high risk of cross-contamination based infection, as the virus spreads via skin to skin contact, and is as dangerous and transmissible as Golden Staf Infection.

In 1988 the Scientists at the CDC advised for the ACAM2000 to be used provisionally on a case by case basis, as Commercial Pharmaceutical use of the Vaccine could cause its own Epidemic. 

Due to the live Vaccinia Virus in the ACAM2000, it is possible to self-inoculate yourself from touching the vaccine site or through prolonged physical exposure with a person Vaccinated with the ACAM2000 Vaccine.

 If you have a diagnosed skin condition (such as Eczema or Psoriasis), any Heart Conditions (E.g. Myocarditis or Pericarditis), any damage to the Cerebral Cortex or Central Nervous System (E.g. Stroke, Acquired Brain Injury "ABI" or Cerebral Palsy), or any Immunocompromising Conditions (E.g. Cancer or Fibromyalgia) are at a High Risk of developing Severe Side Effects of either receiving the ACAM2000 or accidently being Inoculated through physical contact with the Inoculation Site and the resulting Scab or through a period of time in close proximity with someone who has been Inoculated, 

For example; 

A hug or sleeping in the same room has been documented between Vaccinated and Unvaccinated Siblings in 1988. One child was Inoculated with ACAM2000, the other child was not. Within 24 hours, the child who was not Inoculated had contracted the Vaccinia Virus.

The CDC also said in 1988 that the ACAM 2000 was not recommended for anyone who has already been Inoculated or anyone who has contracted and recovered from the Smallpox (or similar viruses like Chickenpox). 

The CDC also outlined that the ACAM2000 was not recommended for the treatment of Monkeypox, as the ACAM2000 will not be effective against the Monkeypox and as a consequence, the risks of severe side-effects and high transmissibility of the Vaccinia Virus outweighed the benefits. 

It goes without saying, that if there is a choice between the two vaccines the Bavarian Nordic would be the preferred option. 

Except, the Bavarian-Nordic Company has told the American Government that they cannot meet the production quota of "Jynneos" to treat Monkeypox (3.5 million doses approx.), and instead told the American Government they could manufacture 1 million doses for the American Government to distribute to the public.

 As a result the American Government are in constant consultation with the CDC, NAIH, NIH, WHO etc. about the possibility of using the ACAM2000 to bridge the gap.

What does this mean for Australia?

This means that the 450,000 of the 3rd-generation Bavarian-Nordic "Jynneos" vaccine that the Australian announced it would purchase for the treatment of Monkeypox may be the only doses they can purchase, due to the demand for "Jynneos" globally.

 As a result, the Australian Government will be following the American Government's lead and use ACAM2000 to meet public demand for treatment for Monkeypox.

Unlike America, Australia still has Public Health Laws that enforce medical treatments to the public during any WHO declared pandemic.

In light of the mess and pain we are seeing playing out from the Coronavirus and its subsequent vaccine, as well as the Mainstream Media and Government Censorship on the topic. Every person that reads this can understand why this information needs to be shown to every person in our beautiful Island Nation of Australia, as fast, and as soon as possible.